English | 简体中文 | 繁體中文 | 한국어
Share:
Presentation of Telenor's first quarter 2018 results on 24 April 2018

The Telenor Group will release its financial results for the 1st quarter 2018 on 24 April.

Please see below for details about the presentation and conference call for journalists, investors and analysts.

When:  Tuesday 24 April, 0900 CET / 0800 UK TIME

Where: Telenor Expo Visitor Centre, Snarøyveien 30, Fornebu


The presentation will be held in English. If you are unable to attend the presentation, we offer two other options:


1) Watch the presentation live on the internet


The webcast link will be posted on our website and will also be available retrospectively.

2)Listen to the presentation on the phone


This service also allows you to ask questions at the Q&A session at the end of the presentation. To participate in the conference call:

  • Dial
    • +47 2100 2610 (local Norway)
    • +46 (0)8 5033 6574 (local Sweden)
    • +44 (0)330 336 9105 (local UK)
    • +1 929-477-0353 (local US)

  • Please state confirmation code 9600829, your name and company to the operator
  • For the Q&A session: to queue up for questions please press *1


The Q1 material will be available on our website from 0700 CET / 0600 UK time on
24 April 2018 on this link:

https://www.telenor.com/investors/reports/2018/telenor-groups-results-for-the-1st-quarter-2018/


Best regards,


Telenor Investor Relations





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Telenor via Globenewswire

Copyright © Thomson Reuters 2018. All rights reserved.
Press Releases
Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook  
Apr 21, 2018 00:30 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 21:33 ET
BOURBON: Positive progress in negotiations with lenders  
Apr 20, 2018 18:30 ET
Hubbell Incorporated Declares Regular Quarterly Dividend  
Apr 20, 2018 16:01 ET
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States  
Apr 20, 2018 15:23 ET
Heineken Holding N.V. - Amendments to the Articles of Association  
Apr 20, 2018 15:18 ET
Lubrizol Presents Estane® TPU and Other Innovations for Consumer, Industrial, Footwear and Electronics Applications at Chinaplas 2018  
Apr 20, 2018 12:03 ET
Lipotec Active Ingredients Becomes Umbrella Brand  
Apr 19, 2018 23:43 ET
LEH PHARMA LTD.: Company Update  
Apr 18, 2018 19:34 ET
Tusk Therapeutics presents data on to its anti-CD25 programme at AACR Annual Meeting 2018  
Apr 18, 2018 19:33 ET
More News >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: